in the United Kingdom
The ambition of Sanofi is to become
a diversified global healthcare leader,
focused on patients' needs.
Sanofi Group in the United Kingdom
The ambition of Sanofi is to become a diversified global healthcare leader, focused on patients' needs.
Sanofi UK, a subsidiary of the global pharmaceutical company Sanofi, is a dynamic, rapidly evolving organisation that is working to meet the needs of healthcare professionals and their patients.
This website explains our company background, values and products. There are also details of the therapy areas we specialise in and latest company news.
As well as updates on the latest developments, you’ll find details of what we do, the exciting career opportunities we offer and the initiatives we undertake as part of our wider humanitarian responsibility to promote health.
Sanofi is the fourth largest pharmaceutical company in the world and the largest in emerging markets.
With more than 100,000 employees in 110 countries, Sanofi has core strengths in the field of healthcare: a worldwide presence, market leadership in vaccines, major biological products and a strong and long-established presence in emerging markets.
Company business activities also include consumer healthcare products, generics and animal health products.
We hope this website gives you an enjoyable introduction to Sanofi in the UK, but if you have any questions or would like any additional information, please feel free to contact us.
Thank you for taking the time to visit the Sanofi UK website
One Onslow Street
Tel: 01483 505 515
Fax: 01483 535 432
Sanofi Diabetes Products
If you have any questions relating to any of Sanofi's diabetes products or services, or experience difficulty in getting supply of any Sanofi diabetes products,
Sanofi in the UK
Find out more about Sanofi UK's business units and locations, our investment in research and development, and our product pipeline
The Forgotten 10,000 - Getting it Right for Men with Prostate Cancer
Sanofi hosts QiC Programme Awards
Monster Manor App
Public Declaration of Payments for Healthcare Professionals
Disclosure of information about on-going clinical trials and results
Patient Group Bursary Scheme
December 19, 2013
Councillor thanks Sanofi for leaving ‘inheritance for the future’ as company
December 18, 2013
The All Wales Medicines Strategy Group (AWMSG) accepts one-daily Lyxumia®(Lixisenatide) for treatment of type 2 diabetes in Wales
November 13, 2013
Surrey Puts the Spotlight on Raising Awareness of Diabetes